Wedbush analyst Yun Zhong initiated coverage of Protagonist Therapeutics (PTGX) with an Outperform rating and $58 price target
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTGX:
- PTGX Upcoming Earnings Report: What to Expect?
- Protagonist Therapeutics participates in a conference call with JPMorgan
- Walmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
- Protagonist Therapeutics initiated with a Buy at TD Cowen
- Protagonist Therapeutics Board and Audit Committee Changes